Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNYNF)
OTHER OTC:SNYNF
SNYNF Analyst Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SNYNF Stock 12 Month Forecast
Average Price Target
$126.72
▲(21.87% Upside)
| Highest Price Target$137.05 | Average Price Target$126.72 | Lowest Price Target$100.87 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bernstein
Reiterated
04/03/25
Leerink Partners
Reiterated
03/30/25
J.P. Morgan
Reiterated
03/25/25
Deutsche Bank
Reiterated
03/21/25
Goldman Sachs
Initiated
03/21/25
Jefferies
Reiterated
03/10/25
Berenberg Bank
Reiterated
03/04/25
DZ BANK AG
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/31/25
Barclays
$131.57→$137.05
Buy
31.80%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
$134.85
Buy
29.69%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
$100.87
Hold
-2.99%
Downside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Citi
$137.05→$142.53
Buy
37.07%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
$129.37→$137.05
Buy
31.80%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
Reiterated
04/03/25
Leerink Partners
Reiterated
03/30/25
J.P. Morgan
Reiterated
03/25/25
Deutsche Bank
Reiterated
03/21/25
Goldman Sachs
Initiated
03/21/25
Jefferies
Reiterated
03/10/25
Berenberg Bank
Reiterated
03/04/25
DZ BANK AG
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/31/25
Barclays
$131.57→$137.05
Buy
31.80%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
$134.85
Buy
29.69%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
$100.87
Hold
-2.99%
Downside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Citi
$137.05→$142.53
Buy
37.07%
Upside
Reiterated
09/16/24
Sanofi (SAN:FP) (SNY) PT Raised to EUR130 at Citi, sees 'a highly attractive risk-reward'Citi analyst Peter Verdult raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR130.00 (from EUR125.00) while maintaining a Buy rating.
Guggenheim
$129.37→$137.05
Buy
31.80%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Best Analysts Covering Sanofi
Which Analyst Should I Follow If I Want to Buy SNYNF and Sell After:
1 Month
xxx
Success Rate
11/14 ratings generated profit
Average Return
+1.21%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 78.57% of your transactions generating a profit, with an average return of +1.21% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
Average Return
+1.51%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.51% per trade.
1 Year
Success Rate
16/22 ratings generated profit
Average Return
+3.66%
reiterated a buy rating 2 months ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +3.66% per trade.
2 Years
xxx
Success Rate
14/19 ratings generated profit
Average Return
+9.85%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.68% of your transactions generating a profit, with an average return of +9.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SNYNF Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
15
16
20
20
11
Hold
8
7
8
10
5
Sell
5
2
2
0
0
Strong Sell
0
0
0
0
0
total
28
25
30
30
16
Each month's total comprises the sum of three months' worth of ratings.
SNYNF Financial Forecast
SNYNF Stock Forecast FAQ
What is SNYNF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is $126.72.
What is SNYNF’s upside potential, based on the analysts’ average price target?
Sanofi has 21.87% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SNYNF a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
What is Sanofi’s price target?
The average price target for Sanofi is $126.72. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $137.05 ,the lowest forecast is $100.87. The average price target represents 21.87% Increase from the current price of $103.98.
The highest analyst price target is $137.05 ,the lowest forecast is $100.87. The average price target represents 21.87% Increase from the current price of $103.98.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of SNYNF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.